Cartherics was formed in 2015 and began work in 2016. By 2022 there were 45 members of staff and principal consultants and the company opened new state of the art PC2 and clean room laboratories close to Monash University. The company is establishing clinical scale product manufacturing and plans to enter clinical trials in 2023 (first autologous product) with other products closely following in 2024 and 2025. The pipeline of products is growing, and the company has the capacity to continue to expand as it receives further grants and investment. The company has a strong work ethic and there are great opportunities for staff to grow with the company. It has strong connections to Monash University, Peter MacCallum Cancer Centre and other key partners that enables an innovative environment to flourish and expand.